アンチセンス技術の医薬品への応用 - 抗炎症役としての可能性 -
スポンサーリンク
概要
- 論文の詳細を見る
Antisense DNA are able to bind to complementary sequences in DNA, pre-mRNA, mRNA and thus, interrupt gene expression with high specificity. This innovative concept has aroused great attention of pharmaceutical scientists in developing of antisense DNA as potential therapeutic reagents. However, this approach has several shortcomings including instability, low membrane permeability. Although modified DNA have been synthesized to overcome these shortcomings, there is no analogue structure yet devised fulfils all the requirements of an ideal antisense effector so far. For the successful application of antisense DNA, it is prerequisite to take considerations in terms of biological stability, cellular uptake, hybridization efficiency, non-toxicity and delivery tools. In this review, basic concept of antisense strategy and possible application of antisense DNA as anti-inflammatory reagents will be discussed. Furthermore, the current trends and future prospects of antisense DNA will be addressed.
- 日本DDS学会の論文
日本DDS学会 | 論文
- 固形腫瘍における分子標的薬の現状と課題 : 腎がんの経験から
- 前立腺がんにおけるホルモン療法
- ホルモン製剤のDDSの基礎と臨床 : 特集によせて
- SN-38内包高分子ミセルNK012日米独立 phase I 試験
- 多機能性エンベロープ型ナノ構造体による人工遺伝子デリバリーシステムの創製 : 第7回日本DDS学会永井賞受賞によせて